Rigel Pharma (RIGL) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $48.50 --0%
Revenue Growth %: +15.2%
Financial Fact:
Interest income: 110K
Today's EPS Names:
PMCB, CULP, HURC, More
Revenue Growth %: +15.2%
Financial Fact:
Interest income: 110K
Today's EPS Names:
PMCB, CULP, HURC, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of ($0.16), $0.01 worse than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
- UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
